Substances & reference · openFDA

Historical FDA documents

FDA press releases and papers from the agency's history, as full text. 8,858 records; openFDA updated it 2026-11-09. About this dataset

26 records match “testosterone”

  • For Immediate Release: May 15, 2013

    FDA NEWS RELEASE For Immediate Release: May 15, 2013 En Espafiol FDA approves new drug for advanced prostate cancer Xofigo approved three months ahead of schedule under priority review program The U.S. Food and Drug Admin…

    Press release2 pages
  • For Immediate Release: July 26, 2013

    FDA NEWS RELEASE For Immediate Release: July 26, 2013 En Espafiol FDA warns consumers about health risks with Healthy Life Chemistry dietary supplement Laboratory tests indicate presence of anabolic steroids Today, the U…

    Press release2 pages
  • For Immediate Release: Aug. 31, 2012

    FDA NEWS RELEASE For Immediate Release: Aug. 31, 2012 FDA approves new treatment for a type of late stage prostate cancer The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late…

    Press release2 pages
  • For Immediate Release: Dec. 10, 2012

    FDA NEWS RELEASE For Immediate Release: Dec. 10, 2012 FDA expands Zytiga’s use for late-stage prostate cancer Drug can now be used before treatment with chemotherapy The U.S. Food and Drug Administration today expanded…

    Press release2 pages
  • For Immediate Release: April 28, 2011

    FDA NEWS RELEASE For Immediate Release: April 28, 2011 FDA approves Zytiga for late-stage prostate cancer The U.S. Food and Drug Administration today approved Zytiga (abiraterone acetate) in combination with prednisone…

    Press release2 pages
  • For Immediate Release: June 17, 2010

    FDA NEWS RELEASE For Immediate Release: June 17, 2010 FDA Approves New Treatment for Advanced Prostate Cancer The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combi…

    Press release2 pages
  • For Immediate Release: May 3, 2010

    FDA NEWS RELEASE For Immediate Release: May 3, 2010 FDA Conducting Safety Review of Commonly Used Prostate Cancer Drugs Preliminary review suggests an increase in the risk of diabetes and certain cardiovascular diseases…

    Press release2 pages
  • For Immediate Release: Oct. 20, 2010

    FDA NOTE TO CORRESPONDENTS For Immediate Release: Oct. 20, 2010 FDA: Include warnings on risk for class of prostate cancer drugs The U.S. Food and Drug Administration today asked manufacturers to add new warnings to lab…

    Press release1 pages
  • FDA NEWS RELEASE FOR IMMEDIATE RELEASE

    FDA NEWS RELEASE FOR IMMEDIATE RELEASE May 7, 2009 Testosterone Gel Safety Concerns Prompt FDA to Require Label Changes, Medication Guide The U.S. Food and Drug Administration today announced that it is requiring manufa…

    Press release2 pages
  • FDA NEWS RELEASE FOR IMMEDIATE RELEASE

    FDA NEWS RELEASE FOR IMMEDIATE RELEASE May 11, 2009 Dietary Supplements Worth $1.3 Million Condemned and Forfeited to the United States Under Consent Decree FDA alleged ’Body-building’ products contained unapproved food…

    Press release2 pages
  • FDA NEWS RELEASE FOR IMMEDIATE RELEASE

    FDA NEWS RELEASE FOR IMMEDIATE RELEASE Dec. 29, 2008 FDA Approves Drug for Patients with Advanced Prostate Cancer The US. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug…

    Press release2 pages
  • FDA NEWS RELEASE FOR IMMEDIATE RELEASE

    FDA NEWS RELEASE FOR IMMEDIATE RELEASE April 19, 2004 Acting FDA Commissioner Dr. Lester M. Crawford Outlines Science-Based Plan for Dietary Supplement Enforcement Speaking before the American Society for Pharmacology a…

    Press release2 pages
  • NEWS RELEASE FOR IMMEDIATE RELEASE

    NEWS RELEASE FOR IMMEDIATE RELEASE Thursday, March 11, 2004 HHS LAUNCHES CRACKDOWN ON PRODUCTS CONTAINING ANDRO FDA Warns Manufacturers To Stop Distributing Such Products HHS Secretary Tommy 6. Thompson today announced…

    Press release3 pages
  • FDA Approves New Drug for Advanced Prostate Cancer

    FDA Approves New Drug for Advanced Prostate Cancer .. . m“; EDA Homefiage | Search FDA Site l FDA A-Z Index | Contact_F_DA FDA Talk Paper T03 '82 . Media Inquiries: 301 827-6242 November 25, 200 3 ‘ Consumer Inquiries: 8…

    talk2 pages
  • NATIONWIDE ALERT ON INJECTABLE DRUGS PREPARED BY URGENT CARE PHAR... Page 1 of 2

    NATIONWIDE ALERT ON INJECTABLE DRUGS PREPARED BY URGENT CARE PHAR... Page 1 of 2 L15 Fem! and 9mg Adminisgmzian FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and a…

    talk2 pages
  • F D A ~ . 1' £000 AND DRUG ADMINISTRATION . ‘ U.S. Department of Health and Human Services Public Health Serv…

    F D A ~ . 1' £000 AND DRUG ADMINISTRATION . ‘ U.S. Department of Health and Human Services Public Health Service 5600 Fishers Lane Rockville. Maryland 20857 ‘ ) FDA Talk Papets are prepared by the Press Office to guide F…

    talk3 pages
  • i , . i . poop AND onus ADhflNISTRA'l'ION

    i , . i . poop AND onus ADhflNISTRA'l'ION . U~S-.Depuunem oft-lam: and gm 5,". h,- ~- - — --- _' . - Public Health Service 5600 PM me we. mamas-7' 'FDATilkPapclsmplepucdhydachOfiiocuoguidc qusdomfiomdscpubliconsybiecoofmue…

    talk6 pages
  • 0.8. DEPARTMENT OF HEALTH AND HUMAN SERVICES

    W1 ‘ IIHQI‘“ maps» 0.8. DEPARTMENT OF HEALTH AND HUMAN SERVICES P89—l Food and Drug Administration FOR IMMEDIATE RELEASE Faye Peterson - (301) 443-3285 Jan. 30. 1989 (Home) -- (30l) 596-9639 The Food and Drug Administra…

    Press release2 pages
  • =' “j 7 ' rooo AND DRUG murmsmnon , U. S. Department of Health and Human Services Public Health Service 5600…

    (6“. Tron =' “j 7 ' rooo AND DRUG murmsmnon , U. S. Department of Health and Human Services Public Health Service 5600 Fishcn lane Rockvlllc. Maryland 20857 rDA Tall Papers as: prepared by the Press Office to guide FDA p…

    talk4 pages
  • Food and Drug Administration has deter- mined that opportlmity should be oflered to all interested persons to…

    Food and Drug Administration has deter- mined that opportlmity should be oflered to all interested persons to comment on the text of both the physician labeling and the proposed patient labeling. Al- though the physician…

    Press release6 pages
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.